GEODE CAPITAL MANAGEMENT, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 56 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$402,000
+2.6%
400,0000.0%0.00%
Q3 2020$392,000
+0.3%
400,0000.0%0.00%
Q2 2020$391,000
+5.1%
400,0000.0%0.00%
Q1 2020$372,000
-95.1%
400,000
-95.0%
0.00%
-100.0%
Q4 2019$7,584,000
+235.1%
8,000,000
+220.0%
0.00%0.0%
Q3 2019$2,263,000
-1.4%
2,500,000
-0.4%
0.00%0.0%
Q2 2019$2,295,000
-81.8%
2,510,000
-82.1%
0.00%
-50.0%
Q4 2018$12,634,000
+93.0%
14,000,000
+100.0%
0.00%0.0%
Q3 2018$6,546,000
-52.9%
7,000,000
-53.3%
0.00%
-50.0%
Q2 2018$13,903,000
+58.6%
15,000,000
+50.0%
0.00%
+33.3%
Q1 2018$8,764,000
-0.1%
10,000,0000.0%0.00%0.0%
Q4 2017$8,775,000
+62.3%
10,000,000
+66.7%
0.00%
+50.0%
Q3 2017$5,407,000
-29.4%
6,000,000
-6.6%
0.00%
-50.0%
Q3 2016$7,663,000
-40.7%
6,423,000
-37.7%
0.00%
-42.9%
Q2 2016$12,928,000
+32.5%
10,317,000
+37.6%
0.01%
+40.0%
Q1 2016$9,759,0007,500,0000.01%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2019
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders